It has been found that increased CDC7-dependent replication is a hallmark of the P53 mutation, and the knockdown of Cdc7 expression induces p53-independent apoptosis, suggesting that Cdc7 is a target for cancer treatment [15, 16]. Here, TP53 is linked to cancer.